$14.96
0.493.39%
At Close: -
$14.96
00.00%
After Hours: Aug 23, 4:00 PM EDT
15 minutes delayed
Comments
Loading...
4D Molecular Therapeutics (NASDAQ:FDMT) Stock, Earnings Estimates, EPS, And Revenue
4D Molecular Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 7
EPS Estimate
$-0.700
Quarterly Revenue Estimate
$650K
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$20.2M
Analyze the earnings history of 4D Molecular Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
4D Molecular Therapeutics (FDMT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-08 | $-0.63 | $-0.71 | 11.3 % |
| Mar 2024 | 2024-05-09 | $-0.66 | $-0.74 | 10.8 % |
| Dec 2023 | 2024-02-29 | $-0.77 | $-0.74 | -4.05 % |
| Sep 2023 | 2023-11-09 | $-0.24 | $-0.54 | 55.6 % |
4D Molecular Therapeutics (FDMT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-09 | $28.00K | $780.00K | -96.4 % |
| Dec 2023 | 2024-02-29 | $-17.00K | $2.06M | -100.8 % |
| Sep 2023 | 2023-11-09 | $20.20M | $9.87M | 104.7 % |
| Jun 2023 | 2023-08-09 | $239.00K | $850.00K | -71.9 % |
FAQ
When is 4D Molecular Therapeutics (NASDAQ:FDMT) reporting earnings?
4D Molecular Therapeutics (FDMT) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
What were the latest earnings per share (EPS) for 4D Molecular Therapeutics (NASDAQ:FDMT)?
The Actual EPS was $-0.63, which beat the estimate of $-0.71.
What were 4D Molecular Therapeutics’s (NASDAQ:FDMT) revenues?
The Actual Revenue was $5K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.